A groundbreaking study published in the November issue of Plastic and Reconstructive Surgery—the official medical journal of the American Society of Plastic Surgeons (ASPS)—has identified a potentially critical surgical risk factor in the post-pandemic era. According to researchers, patients with a history of COVID-19 infection who undergo panniculectomy—a procedure to remove excess abdominal skin and fat—face a significantly higher risk of developing venous thromboembolism (VTE), a life-threatening condition involving the formation of dangerous blood clots.
The findings, published by the medical publisher Wolters Kluwer, suggest that clinicians may need to recalibrate how they assess and manage surgical patients who have previously contracted the virus, particularly as the medical community continues to navigate the long-term systemic impacts of the pandemic.
Main Facts: A Hidden Danger in Body Contouring
Panniculectomy is frequently performed on patients who have achieved significant weight loss, either through lifestyle changes or bariatric surgery. The procedure involves the excision of the "panniculus"—the overhanging apron of skin and fat in the lower abdomen. Unlike purely cosmetic procedures, a panniculectomy is often categorized as a functional necessity. It is used to alleviate chronic skin complications such as intertrigo (rashes), recurrent infections, and ulcerations, while also correcting mobility limitations caused by the weight of the excess tissue.
However, any major abdominal surgery carries inherent risks, among which VTE remains a primary concern. VTE occurs when a blood clot forms in a deep vein, typically in the legs (Deep Vein Thrombosis, or DVT), and has the potential to travel to the lungs, resulting in a pulmonary embolism (PE), which can be fatal.
The new research highlights that while standard preventative measures, such as the use of anticoagulant medications (blood thinners) and risk-assessment models like the Caprini score, remain essential, a patient’s COVID-19 history acts as an independent variable that may heighten this danger.
Chronology: From Pandemic Onset to Clinical Insight
The study utilized a vast dataset to examine the evolution of surgical outcomes between 2017 and 2023. By comparing cohorts from the pre-pandemic period to the post-pandemic landscape, researchers sought to isolate the influence of COVID-19 on postoperative recovery.
- 2017–2019 (Pre-Pandemic Baseline): The researchers established a baseline for VTE occurrences during this period. Patients undergoing panniculectomy were assessed using traditional risk factors.
- March 2020–2023 (Pandemic and Post-Pandemic Period): As the virus spread globally, clinical observations began to emerge suggesting that COVID-19 could cause hypercoagulability—a condition where the blood is more prone to clotting.
- The Analysis Period: The study reviewed 7,114 total patients. Of these, 3,015 underwent surgery prior to the onset of the pandemic, while 4,099 underwent the procedure after March 2020.
- The Final Assessment: By comparing the 790 patients who had a documented history of COVID-19 against 3,309 patients who did not, the researchers were able to quantify the specific impact of the infection on surgical safety.
Supporting Data: Quantifying the Risk
The statistical findings of the study are stark. In the initial analysis of the entire cohort, the overall rates of VTE appeared stable: 3.2% before the pandemic and 3.0% after. At first glance, this might suggest that surgical safety protocols had remained consistent and effective.
However, when the researchers peeled back the layers of the data to focus on the COVID-19 history of the post-pandemic group, a significant discrepancy emerged. Among patients who had no history of COVID-19, the VTE rate remained at 2.5%. In contrast, patients with a documented history of the virus exhibited a VTE rate of 4.9%—nearly double the rate of their counterparts.
"Our results demonstrate a significant increase in the incidence of VTE among panniculectomy patients with a history of COVID-19," the authors noted in their report. The study controlled for other common comorbidities—such as heart disease, lung conditions, and vascular disorders—to ensure that the higher clot rate could not be attributed to other known risk factors. The researchers concluded that the hypercoagulable state often induced by COVID-19, which can persist long after the acute infection has resolved, is the most likely culprit for this elevated risk.
Official Responses and Expert Commentary
Lead author Mary Newland, a medical student at Penn State College of Medicine, emphasizes the importance of these findings for the future of plastic and reconstructive surgery.
"Our findings suggest that past COVID may be an additional predisposing risk factor for VTE among patients undergoing panniculectomy," Newland stated. "This may have implications for assessment and prevention of surgical risks of body contouring surgery after major weight loss."
The medical community has responded to these findings with a call for more robust preoperative screening. Because the physiological impact of COVID-19 on the vascular system can be long-lasting, the current standard of care—which relies heavily on pre-pandemic risk assessment models—may be insufficient. The authors stress that this is an emerging field of inquiry. While the correlation is statistically significant, the study serves as a "call to action" for further research to determine exactly how surgeons should adjust their protocols.
Implications for Clinical Practice
The study has significant implications for how plastic surgeons interact with patients preparing for body contouring.
1. Updated Preoperative Screening
Surgeons may now need to incorporate a detailed "COVID history" into their standard preoperative workup. This includes not only the date of infection but also the severity of the initial illness, as systemic inflammation levels during the infection may correlate with long-term vascular health.
2. Tailoring Anticoagulation Strategies
While blood thinners are already standard practice for panniculectomy patients, the study suggests that for those with a history of COVID-19, current dosages or durations of anticoagulant therapy might need to be re-evaluated. "We are seeing the emergence of a new patient population who may be more susceptible to postoperative VTEs," the researchers stated. Whether this necessitates more aggressive or prolonged chemical prophylaxis is a question that requires urgent clinical trials.
3. Patient Education and Informed Consent
Informed consent is a cornerstone of surgical ethics. As a result of this data, surgeons are now in a better position to educate patients about the specific risks associated with their medical history. Patients with a history of COVID-19 can be informed of the elevated risk and participate in shared decision-making regarding the timing of their surgery or the implementation of extra precautions.
4. Future Research Directions
The authors emphasize that this study is an initial step. Future research must address whether the timing of the surgery relative to the COVID-19 infection matters. For example, does a patient who had COVID-19 three months ago face the same risk as someone who had it two years ago? Additionally, more research is needed to determine if these findings hold true across other types of major plastic surgery, such as abdominoplasty or complex reconstruction, where the extent of tissue dissection and the duration of the surgery might further compound the risk of clot formation.
Conclusion: A New Standard of Vigilance
The study in Plastic and Reconstructive Surgery serves as a sobering reminder that the repercussions of the COVID-19 pandemic continue to ripple through the medical field in unexpected ways. By identifying a clear, statistically significant link between prior infection and postoperative VTE, the research provides a vital piece of the puzzle for surgeons dedicated to patient safety.
As the field of plastic surgery continues to advance, the integration of such findings into daily clinical practice will be essential. By acknowledging the unique physiological footprint left by COVID-19, surgeons can provide a higher standard of care, mitigating risks and ensuring that patients who have worked hard to achieve significant weight loss can complete their transformation safely.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. With a deep commitment to evidence-based medicine, Wolters Kluwer continues to support the medical community by publishing high-impact research that drives clinical excellence and improves patient outcomes. For more information, visit www.wolterskluwer.com.
Article Reference: "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19" (doi: 10.1097/PRS.0000000000012202).
About the Author
